BUZZ-U.S. STOCKS ON THE MOVE-Celsus, VBL Therapeutics, Oncolytics, Magnegas
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)
U.S. stock index futures pointed to a quiet open on Tuesday, the first trading session after the S&P 500 closed at a record high, although investors continued to watch the uncertainty over a Greek debt deal and a fragile Ukraine truce.
Dow Jones industrial average futures were down 0.06 percent at 17,971, S&P 500 futures were down 0.13 percent at 2,090.75 and Nasdaq 100 futures were up 0.11 percent at 4,381.75.
** CELSUS THERAPEUTICS PLC, Friday close $6.17, -82.66 pct premarket
The drug developer said a mid-stage study for a skin cream, the lead drug in company's pipeline, did not meet the main goal.
** VBL THERAPEUTICS INC, Friday close $14.11, -51.74 pct premarket
Israeli company said it would stop developing its experimental inflammatory drug to fight ulcerative colitis and psoriasis. Continued...